In agreement with previous studies in different cancer models that combined ATM or PARP inhibitors with either proton or carbon ion irradiation, we determined that pharmacological inhibition of these pathways attenuated cell survival in combination with high LET 223Ra radiation [35,36]. This evidence concerns the gene PARP1 and cancer.